Sodium butyrate activates Notch1 signaling, reduces tumor markers, and induces cell cycle arrest and apoptosis in pheochromocytoma

American Journal of Translational Research

Volumn 1, Issue 2, 2009, Pages 178-183

  Cayo, Max A ^a   Cayo, Ashley K ^a   Jarjour, Sarah M ^a   Chen, Herbert ^a  

^a UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

Author keywords

Butyrate; HDAC inhibitor; Neuroendocrine; Notch 1; PC 12; Pheochromocytoma

Indexed keywords

BUTYRIC ACID; CASPASE 3; CYCLIN D1; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; NOTCH1 RECEPTOR; PROTEIN P21; TRANSCRIPTION FACTOR MASH1;

ANIMAL CELL; APOPTOSIS; ARTICLE; CELL CYCLE ARREST; CELL PROLIFERATION; CONTROLLED STUDY; DISEASE MARKER; DOSE RESPONSE; DRUG MECHANISM; DRUG PROTEIN BINDING; DRUG TARGETING; IN VITRO STUDY; NONHUMAN; PHEOCHROMOCYTOMA; PROTEIN CLEAVAGE; PROTEIN EXPRESSION; RAT; SIGNAL TRANSDUCTION; TUMOR CELL;

EID: 77953416179     PISSN: None     EISSN: 19438141     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Adler JT, Meyer-Rochow GY, Chen H, Benn DE, Robinson BG, Sippel RS, Sidhu SB. Pheochromocytoma: Current Approaches and Future Directions. Oncologist. 2008.
2. Sheps SG, Jiang NS, Klee GG. Diagnostic evaluation of pheochromocytoma. Endocrinol Metab Clin North Am. 1988; 17: 397-414.
3. Grant. Pheochromocytoma. Textbook of Endocrine Surgery. Philadelphia, PA: Elsevier Saunders Co.; 2005. p. 621-33.
4. Walther MM, Keiser HR, Linehan WM. Pheochromocytoma: evaluation, diagnosis, and treatment. World J Urol. 1999; 17: 35-9.
5. Bravo EL. Pheochromocytoma. Cardiol Rev. 2002; 10: 44-50.
6. Chen H, Doppman JL, Chrousos GP, Norton JA, Nieman LK, Udelsman R. Adrenocorticotropic hormone-secreting pheochromocytomas: the exception to the rule. Surgery. 1995; 118:988-94; discussion 94-5.
7. Kuruba R, Gallagher SF. Current management of adrenal tumors. Curr Opin Oncol. 2008; 20: 34-46.
8. Eisenhofer G, Bornstein SR, Brouwers FM, Cheung NK, Dahia PL, de Krijger RR, Giordano TJ, Greene LA, Goldstein DS, Lehnert H, Manger WM, Maris JM, Neumann HPH, Pacak K, Shulkin BL, Smith DI, Tischler AS, Young WF Jr. Malignant pheochromocytoma: current status and initiatives for future progress. Endocr Relat Cancer. 2004; 11: 423-36.
9. Goldstein RE, O'Neill JA, Jr., Holcomb GW, 3rd, Morgan WM 3rd, Neblett WW, 3rd, Oates JA, Brown N, Nadeau J, Smith B, Page DL, Abumrad NN, Scott HW Jr. Clinical experience over 48 years with pheochromocytoma. Ann Surg. 1999; 229: 755-64; discussion 64-6.
10. Kunnimalaiyaan M, Chen H. Tumor suppressor role of Notch-1 signaling in neuroendocrine tumors. Oncologist. 2007; 12: 535-42.
11. Artavanis-Tsakonas S, Rand MD, Lake RJ. Notch signaling: cell fate control and signal integration in development. Science. 1999; 284: 770-6.
12. Kunnimalaiyaan M, Vaccaro AM, Ndiaye MA, Chen H. Overexpression of the NOTCH1 intracellular domain inhibits cell proliferation and alters the neuroendocrine phenotype of medullary thyroid cancer cells. J Biol Chem. 2006; 281: 39819-30.
13. Kunnimalaiyaan M, Traeger K, Chen H. Conservation of the Notch1 signaling pathway in gastrointestinal carcinoid cells. Am J Physiol Gastrointest Liver Physiol. 2005; 289: G636-42.
14. Greenblatt DY, Vaccaro AM, Jaskula-Sztul R, Ning L, Haymart M, Kunnimalaiyaan M, Chen H. Valproic acid activates notch-1 signaling and regulates the neuroendocrine phenotype in carcinoid cancer cells. Oncologist. 2007; 12: 942-51.
15. Greenblatt DY, Cayo MA, Adler JT, Ning L, Haymart MR, Kunnimalaiyaan M, Chen H. Valproic acid activates Notch1 signaling and induces apoptosis in medullary thyroid cancer cells. Ann Surg. 2008; 247: 1036-40.
16. Greenblatt DY, Cayo M, Ning L, Jaskula-Sztul R, Haymart M, Kunnimalaiyaan M, Chen H. Suberoyl bishydroxamic acid inhibits cellular proliferation by inducing cell cycle arrest in carcinoid cancer cells. J Gastrointest Surg. 2007; 11: 1515-20; discussion 20.
17. Shao Y, Gao Z, Marks PA, Jiang X. Apoptotic and autophagic cell death induced by histone deacetylase inhibitors. Proc Natl Acad Sci U S A. 2004; 101: 18030-5.
18. Sealy L, Chalkley R. The effect of sodium butyrate on histone modification. Cell. 1978; 14: 115-21.
19. Byrd JC, Alho H. Differentiation of PC12 pheochromocytoma cells by sodium butyrate. Brain Res. 1987; 428: 151-5.
20. Van Gompel JJ, Kunnimalaiyaan M, Holen K, Chen H. ZM336372, a Raf-1 activator, suppresses growth and neuroendocrine hormone levels in carcinoid tumor cells. Mol Cancer Ther. 2005; 4: 910-7.
21. Chen H, Thiagalingam A, Chopra H, Borges MW, Feder JN, Nelkin BD, Baylin SB, Ball DW. Conservation of the Drosophila lateral inhibition pathway in human lung cancer: a hairy-related protein (HES-1) directly represses achaete-scute homolog-1 expression. Proc Natl Acad Sci U S A. 1997; 94: 5355-60.
22. Sriuranpong V, Borges MW, Strock CL, Nakakura EK, Watkins DN, Blaumueller CM, Nelkin BD, Ball DW. Notch signaling induces rapid degradation of achaete-scute homolog 1. Mol Cell Biol. 2002; 22: 3129-39.
23. Liu X, Kim CN, Yang J, Jemmerson R, Wang X. Induction of apoptotic program in cell-free extracts: requirement for dATP and cytochrome c. Cell. 1996; 86: 147-57.
24. Miura M, Zhu H, Rotello R, Hartwieg EA, Yuan J. Induction of apoptosis in fibroblasts by IL-1 beta-converting enzyme, a mammalian homolog of the C. elegans cell death gene ced-3. Cell. 1993; 75: 653-60.
25. Ning L, Greenblatt DY, Kunnimalaiyaan M, Chen H. Suberoyl bis-hydroxamic acid activates Notch-1 signaling and induces apoptosis in medullary thyroid carcinoma cells. Oncologist. 2008; 13: 98-104.